Mark Kelly, NASA (image) NASA/Johnson Space Center Share Print E-Mail Caption Antibiotic Effectiveness in Space (AES-1) consists of Commercial Generic Bioprocessing Apparatus and 16 Group Activation Packs. Here, astronaut Mark Kelly works with similar hardware used in the NLP-Vaccine-10 investigation. Credit BioServe Space Technologies Usage Restrictions Image Credit: BioServe Space Technologies Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.